Joseph Juliano, MD
Ophthalmology · Tucson, AZNPI 1982107702
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,386 of the $8,581 with a category attached, or 74.4%. 19 manufacturers reported payments, led by Alcon at 34.1% of the total. Reporting peaked in 2022 at $2,768 and has fallen 69.5% since, to $844 in 2025.
Across 109 payments — averaging $78.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$3K
- Alimera Sciences, Inc.$2K
- Regeneron Healthcare Solutions, Inc.$717
- Apellis Pharmaceuticals, Inc.$475
- AbbVie$363
- Bausch & Lomb Americas Inc.$305
- plus $2K from 13 others
What the payments were for
- Speaking & faculty fees$8109%
- Travel & lodging$1,38516%
- Food & beverage$6,38674%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 24 | $2,924 |
| Alimera Sciences, Inc. | 10 | $2,235 |
| Regeneron Healthcare Solutions, Inc. | 19 | $717 |
| Apellis Pharmaceuticals, Inc. | 11 | $475 |
| AbbVie | 7 | $363 |
| Bausch & Lomb Americas Inc. | 9 | $305 |
| Astellas Pharma US Inc | 5 | $255 |
| Genentech USA, Inc. | 4 | $231 |
| Coherus Oncology, Inc. | 4 | $208 |
| Glaukos Corporation | 1 | $182 |
| Mallinckrodt Hospital Products Inc. | 2 | $162 |
| Regeneron | 2 | $137 |
| Eyepoint US, Inc. | 2 | $130 |
| Biogen | 3 | $74 |
| Genentech, Inc. | 1 | $73 |
| Sandoz | 2 | $53 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $23 |
| Amgen | 1 | $18 |
| Dutch Ophthalmic, USA | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,581 in reported general payments places this provider in the 85th percentile of 310 ophthalmology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 201 | $9,745 |
| NevanacNepafenac | 15 | $4,716 |
| Ketorolac Tromethamine | 92 | $1,807 |
| Difluprednate | 13 | $1,626 |
| Brimonidine Tartrate | 37 | $1,467 |
| Atropine Sulfate | 41 | $1,246 |
| Gentamicin Sulfate | 106 | $1,132 |
| Dorzolamide Hcl | 18 | $502 |
| Latanoprost | 42 | $491 |
| Timolol Maleate | 24 | $405 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 17 | $338 |
| Ofloxacin | 26 | $269 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Tucson
- Martin WorrallTucson$12K
- Brock BakewellTucson$12K
- Sean GarrityTucson$11K
- Andreas GonzalezTucson$11K
- Lynn PolonskiTucson$9K
- Ajay SananTucson$8K
- Michael DiesenhouseTucson$7K
- Ovette VillavicencioTucson$6K
- Rachel HuynhTucson$6K
- Patrick TsaiTucson$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.